Adefovir Expanded Access Enrollment Cited By Gilead To Support Approval
Executive Summary
Gilead's adefovir dipivoxil is currently being used by physicians responsible for 70% of the prescriptions for AIDS antiretroviral therapies in the U.S., via the company's expanded access program.